Variability of contribution of vitamin D receptor gene polymorphisms to outcome of HLA-matched sibling allogeneic bone marrow transplantation
Graft-versus-host disease (GVHD) remains one of the major complications of hematopoietic stem cell transplantation (HSCT). Several etiological factors were investigated. Among these, vitamin D and hence its receptor (VDR) gene polymorphisms have gained much interest; however, the results are still controversial. Using PCR-RFLP, we genotyped VDR polymorphisms FokI (rs10735810), ApaI (rs7975232), and Taq1 (rs731236) in 80 patient/donor pairs according to DNA availability. No association was encountered between VDR polymorphisms and GVHD. Neither was there any impact on survival. Only grade II-IV acute GVHD was associated with inferior overall (p = .01), but not disease-free survival. The controversy between our results and the literature may be attributed to marked variability in the relative distribution of VDR genotypes in different populations. Also different environmental factors, including exposure to sun, may ensure vitamin D sufficiency nullifying the impact of VDR polymorphisms.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
|---|---|
| Enthalten in: |
Leukemia & lymphoma - 59(2018), 12 vom: 01. Dez., Seite 2963-2972 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kamel, Azza M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
GVHD |
|---|
| Anmerkungen: |
Date Completed 24.06.2019 Date Revised 24.06.2019 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/10428194.2018.1459608 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM286150123 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM286150123 | ||
| 003 | DE-627 | ||
| 005 | 20231225051026.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/10428194.2018.1459608 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0953.xml |
| 035 | |a (DE-627)NLM286150123 | ||
| 035 | |a (NLM)29972092 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kamel, Azza M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Variability of contribution of vitamin D receptor gene polymorphisms to outcome of HLA-matched sibling allogeneic bone marrow transplantation |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.06.2019 | ||
| 500 | |a Date Revised 24.06.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Graft-versus-host disease (GVHD) remains one of the major complications of hematopoietic stem cell transplantation (HSCT). Several etiological factors were investigated. Among these, vitamin D and hence its receptor (VDR) gene polymorphisms have gained much interest; however, the results are still controversial. Using PCR-RFLP, we genotyped VDR polymorphisms FokI (rs10735810), ApaI (rs7975232), and Taq1 (rs731236) in 80 patient/donor pairs according to DNA availability. No association was encountered between VDR polymorphisms and GVHD. Neither was there any impact on survival. Only grade II-IV acute GVHD was associated with inferior overall (p = .01), but not disease-free survival. The controversy between our results and the literature may be attributed to marked variability in the relative distribution of VDR genotypes in different populations. Also different environmental factors, including exposure to sun, may ensure vitamin D sufficiency nullifying the impact of VDR polymorphisms | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a GVHD | |
| 650 | 4 | |a HSCT | |
| 650 | 4 | |a VDR | |
| 650 | 4 | |a vitamin D | |
| 650 | 7 | |a HLA Antigens |2 NLM | |
| 650 | 7 | |a Receptors, Calcitriol |2 NLM | |
| 650 | 7 | |a VDR protein, human |2 NLM | |
| 700 | 1 | |a El-Fishawi, Sally |e verfasserin |4 aut | |
| 700 | 1 | |a Rasekh, Eman O |e verfasserin |4 aut | |
| 700 | 1 | |a Radwan, Eman R |e verfasserin |4 aut | |
| 700 | 1 | |a Zeidan, Ashraf |e verfasserin |4 aut | |
| 700 | 1 | |a El-Said, Abeer |e verfasserin |4 aut | |
| 700 | 1 | |a Zaky, Amen H |e verfasserin |4 aut | |
| 700 | 1 | |a Abdelfattah, Maged |e verfasserin |4 aut | |
| 700 | 1 | |a Refaat, Ahmed |e verfasserin |4 aut | |
| 700 | 1 | |a Abdelfattah, Raafat |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia & lymphoma |d 1989 |g 59(2018), 12 vom: 01. Dez., Seite 2963-2972 |w (DE-627)NLM012624047 |x 1029-2403 |7 nnns |
| 773 | 1 | 8 | |g volume:59 |g year:2018 |g number:12 |g day:01 |g month:12 |g pages:2963-2972 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/10428194.2018.1459608 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 59 |j 2018 |e 12 |b 01 |c 12 |h 2963-2972 | ||